Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06613802
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-12
Brief Title:
Prevalence of Gabapentinoids and Opioids in Geriatric Falls Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Prevalence of Gabapentinoids in Geriatric Falls Outpatients in Aalborg in 2013-2014 2018-2019 and 2023
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study investigates the prescription patterns of gabapentinoids gabapentin and pregabalin in a geriatric fall clinic in Aalborg Denmark between 2013 and 2023 Gabapentinoids often prescribed for neuropathic pain have seen increased off-label usage particularly as alternatives to opioids Despite the lack of robust evidence supporting their efficacy in many neuropathic and non-neuropathic pain conditions their use has grown especially in elderly populations This raises concerns about their potential side effects such as drowsiness dizziness and the risk of falls especially when combined with opioids
The study aims to determine the prevalence of gabapentinoid and opioid prescriptions in the clinics and for what type of pain they are prescribed Furthermore the study will look into the development in opioid prescriptions and concomitant gabapentinoidopioid usage in this population
The study is a retrospective chart review of patient charts from the years 2013-2014 2018-2019 and 2023 analyzing patient characteristics comorbidities medication lists and pain classifications
The study aims to determine the prevalence of gabapentinoid and opioid prescriptions in the clinics and for what type of pain they are prescribed Furthermore the study will look into the development in opioid prescriptions and concomitant gabapentinoidopioid usage in this population
The study is a retrospective chart review of patient charts from the years 2013-2014 2018-2019 and 2023 analyzing patient characteristics comorbidities medication lists and pain classifications
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None